Blue Trust Inc’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.42K Sell
20
-253
-93% -$89.3K ﹤0.01% 1770
2026
Q2
$98K Sell
273
-6
-2% -$1.83K ﹤0.01% 1057
2026
Q1
$69.9K Sell
279
-12
-4% -$2.99K ﹤0.01% 1184
2025
Q4
$80.1K Buy
291
+7
+2% +$1.92K ﹤0.01% 1166
2025
Q3
$74.5K Sell
284
-5
-2% -$1.22K ﹤0.01% 1207
2025
Q2
$63.2K Buy
289
+103
+55% +$22K ﹤0.01% 1262
2025
Q1
$41.6K Buy
186
+22
+13% +$6.06K ﹤0.01% 1446
2024
Q4
$53.7K Sell
164
-655
-80% -$206K ﹤0.01% 1275
2024
Q3
$270K Buy
819
+577
+238% +$177K ﹤0.01% 723
2024
Q2
$95.8K Buy
242
+186
+332% +$65.7K ﹤0.01% 999
2024
Q1
$22.2K Sell
56
-10
-15% -$3.7K ﹤0.01% 1192
2023
Q4
$24K Buy
66
+61
+1,220% +$21.6K ﹤0.01% 1217
2023
Q3
$2K Sell
5
-4
-44% -$1.55K ﹤0.01% 1865
2023
Q2
$3K Sell
9
-18
-67% -$6.43K ﹤0.01% 1690
2023
Q1
$7K Sell
27
-16
-37% -$4.68K ﹤0.01% 1717
2022
Q4
$11K Buy
43
+27
+169% +$6.4K ﹤0.01% 1524
2022
Q3
$5K Sell
16
-3
-16% -$914 ﹤0.01% 1594
2022
Q2
$8K Buy
+19
New +$6.18K ﹤0.01% 1308

Other funds holding WST

Blue Trust Inc's WST Position: Q3 2026 in Review

Blue Trust Inc reduced its West Pharmaceutical (WST) stake by 93% in Q3 2026, selling an estimated $89.3K and leaving 20 shares worth $7.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1770.

Blue Trust Inc first reported a position in WST in Q2 2022 and has held it in 18 quarters since. The position peaked at $270K in Q3 2024. 213 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Blue Trust Inc held 20 shares of West Pharmaceutical worth $7.42K as of Q3 2026.
  • Blue Trust Inc sold 253 West Pharmaceutical shares in Q3 2026, an estimated $89.3K.
  • West Pharmaceutical made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #1770 holding.
  • Blue Trust Inc first reported a position in West Pharmaceutical in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust Inc's West Pharmaceutical position peaked at $270K in Q3 2024.
  • 213 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.